Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Hand Surg Eur Vol ; 38(4): 412-7, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23345542

RESUMEN

The dorsoradial flap is a recently described cutaneous flap, which is harvested from the distal forearm and indicated for covering dorsal soft tissue defects of the hand and thumb. Vascularization of the flap is assured by a cutaneous branch of the radial artery, which arises at the level of the first intermetacarpal space and supplies the skin of the distal quarter of the forearm dorsum. This area corresponds to the skin island of the dorsoradial flap. We report our clinical experience on seven patients where this flap was used for covering post-traumatic defects of the thumb. Dimensions of the defect varied from 18 to 28 cm(2). The donor site was skin grafted. All flaps survived and provided satisfactory coverage of the defect. Based on a secondary vascular axis, the flap has a large skin paddle and a wide rotation arc that allows soft tissue reconstruction of the dorsal and radiopalmar areas of the thumb.


Asunto(s)
Antebrazo/cirugía , Procedimientos de Cirugía Plástica/métodos , Colgajos Quirúrgicos/irrigación sanguínea , Pulgar/lesiones , Pulgar/cirugía , Adulto , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
3.
Microsurgery ; 21(8): 357-61, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11757061

RESUMEN

Vein thrombosis is often encountered in microsurgery, especially in the case of crush-avulsion injuries. The aim of this study was to investigate the effect of systemic administration of recombinant tissue-type plasminogen activator (rt-PA) on the patency of the femoral vein of the rat, which had previously sustained a crush-avulsion injury. The study consisted of 3 groups of male Wistar rats, 20 animals each. A standardized crush-avulsion injury model was used. After microvascular repair of the femoral vein, the animals received either normal saline (group A), heparin 100 U/kg body weight (group B), or rt-PA 3.5 mg/kg body weight (group C) systemically. Patency tests were performed at 20 minutes, 48 hours, and 1 week after blood flow reestablishment. According to our results, the patency rate of the rt-PA group was significantly higher than in both the control and heparin groups.


Asunto(s)
Vena Femoral/cirugía , Activadores Plasminogénicos/uso terapéutico , Activador de Tejido Plasminógeno/uso terapéutico , Trombosis de la Vena/prevención & control , Animales , Vena Femoral/lesiones , Masculino , Microcirugia , Ratas , Ratas Wistar , Grado de Desobstrucción Vascular
4.
Microsurgery ; 20(7): 324-30, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11119287

RESUMEN

The present study assesses the effect of recombinant tissue-type plasminogen activator (rt-PA) on the patency rate and healing process of microvascular polytetrafluoroethylene (PTFE) grafts. Wistar rats were used, divided into four groups of 25 animals each. After dissection of the carotid artery a segment of the vessel, 1 cm long, was resected and replaced by equal length graft. Two different type fibril length (30- or 60-microm) grafts of the same wall thickness (0.18 mm) were used. Normal saline or 3 mg/kg of body weight of rt-PA was applied locally in each group of different fibril length grafts. Patency tests were performed at 15 min and 4 weeks after blood flow was reestablished. All grafts were harvested and examined histologically. The results showed that local application of rt-PA improves patency statistically significantly in both types of fibril length grafts. Patency in 60-microm fibril length grafts was statistically significantly higher than that of 30-microm fibril length grafts, whether rt-PA was used or not. The use of rt-PA had no influence on the healing process of either type of graft.


Asunto(s)
Prótesis Vascular , Microcirugia , Politetrafluoroetileno , Proteínas Recombinantes/farmacología , Activador de Tejido Plasminógeno/farmacología , Grado de Desobstrucción Vascular/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Animales , Masculino , Ratas , Ratas Wistar , Procedimientos Quirúrgicos Vasculares
5.
Br J Plast Surg ; 53(6): 508-15, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10927683

RESUMEN

The aim of this study was to prefabricate an axial bio-synthetic flap for reconstruction of circumferential tracheal defects in a rabbit model. Two series of experiments were performed. In the first set of experiments axial island bio-synthetic flaps were prefabricated. These consisted of an inner island de-epithelialised fasciocutaneous flap from a rabbit's ear and an outer polytetrafluoroethylene vascular graft. The flaps were buried at the base of the rabbit's ear for periods of 1, 2 and 3 weeks (groups A, B and C, respectively), 10 flaps per group. Only one flap in group C failed to survive. Clinical and histological assessment, at the completion of each time period, showed that only the viable flaps of group C developed all the characteristics needed for a tracheal substitute. In the second set of experiments the prefabricated bio-synthetic flaps were transferred to the rabbit's neck by means of microvascular anastomoses. Ten such free flaps were buried at the rabbit's neck for 3 weeks (group D). Eight of the flaps remained viable and all the viable flaps had characteristics similar to those of group C. These results demonstrate the feasibility of creating a prefabricated axial bio-synthetic flap (island or free), over a 3-week period, possessing the characteristics needed for a tracheal substitute in a rabbit model.


Asunto(s)
Bioprótesis , Procedimientos de Cirugía Plástica/métodos , Colgajos Quirúrgicos , Enfermedades de la Tráquea/cirugía , Animales , Masculino , Politetrafluoroetileno/uso terapéutico , Conejos , Factores de Tiempo , Supervivencia Tisular
6.
Microsurgery ; 20(2): 52-8, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10702737

RESUMEN

The failure rate of replantations following a crush-avulsion type injury is high. This study has been designed to reproduce an effective standardized crush-avulsion injury model to the femoral artery of the rat and evaluate the antithrombotic efficacy of systemic intravenous administration of recombinant human tissue-type plasminogen activator (rt-PA). The crush-avulsion injury was reproduced by using a bulldog clamp and two hemostats and followed by microvascular repair. The animals were divided into three groups of 20 rats each and received either normal saline, heparin 100 U/kg body weight, or rt-PA 3.5 mg/kg body weight intravenously. Patency tests were performed 20 min and 48 h after blood flow reestablishment. Results showed that this experimental crush-avulsion injury model ensures low patency in the control group, whereas systemic rt-PA administration improves the patency rate statistically significantly compared to control and heparin groups at both 20 min and 48 h postrevascularization.


Asunto(s)
Fibrinolíticos/farmacología , Microcirugia , Activador de Tejido Plasminógeno/farmacología , Grado de Desobstrucción Vascular/efectos de los fármacos , Procedimientos Quirúrgicos Vasculares , Animales , Modelos Animales de Enfermedad , Estudios de Evaluación como Asunto , Arteria Femoral/lesiones , Humanos , Masculino , Distribución Aleatoria , Ratas , Ratas Wistar , Proteínas Recombinantes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA